Iran rises to 7th place among global leaders in regenerative medicine

Pars Today – With approval for six new Advanced Therapy Medicine Products (ATMP), Iran’s global ranking in regenerative medicine has climbed from 12th to 7th place.

Iran’s Headquarters for Stem Cell and Biological Sciences announced that the Islamic Republic has risen from 12th to 7th place globally in regenerative medicine. According to Pars Today, this achievement reflects the development of an innovation ecosystem and targeted support for Iranian knowledge-based companies active in the field.

These products cover strategic areas including cell therapy, tissue engineering, and CAR-T therapy, addressing critical medical needs in Iran such as vitiligo, graft-versus-host disease (GVHD), cerebral palsy (CP), burns, diabetic foot ulcers, osteoarthritis, and leukemia. Some of these therapies also involve cutting-edge technology and have export potential.

Experts believe that continuing this trajectory could establish Iran as a regional hub for regenerative medicine, paving the way for the development of advanced treatments and the export of knowledge-based products. According to official statistics, there are currently 148 licensed ATMP products worldwide, seven of which belong to Iran—highlighting the country’s significant role in this advanced medical field.

Notably, by 2023, only one ATMP product had been produced in Iran, while since then six new advanced cell therapy products have been developed.

These achievements, alongside the expansion of research and production infrastructure, the launch of the national supervised-use platform for advanced therapeutic products (IranATMP.com), streamlined regulatory processes in collaboration with the Food and Drug Organization and the Treatment Deputy of Iran’s Ministry of Health, and the creation of innovative financing tools such as specialized funds and corporate venture capital (CVC) mechanisms, have established a foundation for the continued production, commercialization, and development of both the domestic and export markets for these products.